Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Codexis (CDXS)
NASDAQ:CDXS
Codexis (CDXS) Stock Price & Analysis
637 Followers
CDXS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.45 - $4.91
Previous Close$2.76
Volume342.57K
Average Volume (3M)588.50K
Market Cap
$197.90M
Enterprise Value$139.42M
Total Cash (Recent Filing)$74.60M
Total Debt (Recent Filing)$19.98M
Price to Earnings (P/E)-2.5
Beta2.75
Next Earnings
May 02, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.12
Shares Outstanding70,303,639
10 Day Avg. Volume351,067
30 Day Avg. Volume588,498
Standard Deviation0.23
R-Squared0.22
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.28
Price to Sales (P/S)1.40
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.89
Enterprise Value/Gross Profit1.39
Enterprise Value/Ebitda-1.95
Forecast
1Y Price Target
$7.20Price Target Upside155.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Codexis News
Ownership Overview
66.09% Insiders
23.08% Mutual Funds
9.37% Other Institutional Investors
1.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDXS FAQ
What was Codexis’s price range in the past 12 months?
Codexis lowest stock price was $1.45 and its highest was $4.91 in the past 12 months.
What is Codexis’s market cap?
Currently, no data Available
When is Codexis’s upcoming earnings report date?
Codexis’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were Codexis’s earnings last quarter?
Codexis released its earnings results on Feb 28, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.124 by $0.024.
Is Codexis overvalued?
According to Wall Street analysts Codexis’s price is currently Undervalued.
Does Codexis pay dividends?
Codexis does not currently pay dividends.
What is Codexis’s EPS estimate?
Codexis’s EPS estimate is -$0.18.
How many shares outstanding does Codexis have?
Codexis has 70,303,640 shares outstanding.
What happened to Codexis’s price movement after its last earnings report?
Codexis reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.124. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Codexis?
Among the largest hedge funds holding Codexis’s share is Graham Capital Management, L.P.. It holds Codexis’s shares valued at N/A.
---
Codexis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.20 (155.77% Upside)
$7.20 (155.77% Upside)
Blogger Sentiment
Bullish
CDXS Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 15.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▼ 12.5%
Last 30 Days ▼ 12.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-36.40%
12-Months-Change
Fundamentals
Return on Equity
-65.89%
Trailing 12-Months
Asset Growth
-45.46%
Trailing 12-Months
Company Description
Codexis
Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.
---
CDXS Company Deck
---
CDXS Earnings Call
Q4 2024
0:00 / 0:00
---
CDXS Stock 12 Months Forecast
Average Price Target
$7.20
▲(155.77% Upside)
Technical Analysis
Abeona Therapeutics
―
Arbutus Biopharma
―
ACADIA Pharmaceuticals
―
Acadia Healthcare
―
Best Analysts Covering CDXS
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-20.97%
reiterated a buy rating 2 months ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -20.97% per trade.
---